Cuneo, K. C., Cabrera, A. R., Sampson, J. H., Allen, K. J., Vredenburgh, J. J., Peters, K., … Kirkpatrick, J. (2011). Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma. Journal of Clinical Oncology, 29(15_suppl), 2082–2082. https://doi.org/10.1200/jco.2011.29.15_suppl.2082

Cuneo, K. C., A. R. Cabrera, J. H. Sampson, K. J. Allen, J. J. Vredenburgh, K. Peters, Z. Chang, et al. “Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma.” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 2082–2082. https://doi.org/10.1200/jco.2011.29.15_suppl.2082.

Cuneo KC, Cabrera AR, Sampson JH, Allen KJ, Vredenburgh JJ, Peters K, et al. Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma. Journal of Clinical Oncology. 2011 May 20;29(15_suppl):2082–2082.

Cuneo, K. C., et al. “Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma.” Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2011, pp. 2082–2082. Crossref, doi:10.1200/jco.2011.29.15_suppl.2082.

Cuneo KC, Cabrera AR, Sampson JH, Allen KJ, Vredenburgh JJ, Peters K, Chang Z, Herndon JE, Desjardins A, Reardon DA, Kirkpatrick J. Safety results from a prospective study of concurrent radiosurgery and bevacizumab for recurrent malignant glioma. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011 May 20;29(15_suppl):2082–2082.